Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept (nasdaq: bioc), a leading provider of molecular diagnostic assays and services, today announced that it has granted inducement stock options to purchase an aggregate of 220,800 shares of its common stock to 16 new employees. these inducement stock options have a grant date of august 31, 2021, and were granted as inducements material to the new employees entering into employment with biocept in accordance with nasdaq listing rule 5635(c)(4). the inducement sto
BIOC Ratings Summary
BIOC Quant Ranking